IMG Pharma to Acquire Matsumoto Pharmaceutical
IMG Pharma signs a definitive agreement to acquire Matsumoto Pharmaceutical, combining biopharmaceutical innovation with manufacturing and OTC capabilities, forming a multi-layered product capability structure.
Matsumoto Pharmaceutical Deal | 28/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy